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Abstract Legislative changes that came into effect in the
UK in April 2012 gave nurse independent prescribers (NIPs)
the power to prescribe schedule 2–5 controlled drugs.
Therefore, suitably qualified UK nurses can now indepen-
dently prescribe any drug for any medical condition within
their clinical competence. The potential benefits of inde-
pendent nurse prescribing include improved access to medi-
cations and more efficient use of skills within the National
Health Service workforce. This review explores the pub-
lished literature (to July 2013) to investigate whether the
predicted benefits of NIPs in mental health settings can be
supported by empirical evidence, with a specific focus on
nurse-led management of patients with attention-deficit/
hyperactivity disorder (ADHD). The most common phar-
macological treatments for ADHD are controlled drugs.
Therefore, the 2012 legislative changes allow nurse-led
ADHD services to offer holistic packages of care for patients.
Evidence suggests that independent prescribing by UK nurses
is safe, clinically appropriate and associated with high levels
of patient satisfaction. The quality of the nurse–patient
relationship and nurses’ ability to provide flexible follow-up
services suggests that nurse-led ADHD services are well
positioned to enhance the outcomes for patients and their
parents/carers. However, the empirical evidence available to
support the value of NIPs in mental health settings is limited.
There is a need for additional high-quality data to verify
scientifically the value of nurse-delivered ADHD care. This
evidence will be invaluable in supporting the growth of nurse-
led ADHD services and for those who support greater
remuneration for the expanded role of NIPs.
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Introduction
In April 2012, UK legislative changes gave nurse indepen-
dent prescribers (NIPs) the power, for the first time, to pre-
scribe schedule 2–5 controlled drugs (Table 1). Nurse
prescribing from a limited formulary was first introduced in
the UK in the 1990s, and in 2001, this was extended to include
a larger range of medicines. In 2002, supplementary pre-
scribing was introduced; this is a voluntary partnership
between an independent prescriber (doctor or dentist) and a
supplementary prescriber (e.g. a nurse) and, with the patient’s
agreement, allows the supplementary prescriber to prescribe
medicines within an agreed clinical management plan. Sup-
plementary prescribing was extended to include controlled
drugs in 2005. The introduction in 2006 of independent pre-
scribing enabled nurses to prescribe any medication from the
British National Formulary, with the exception of controlled
drugs. The 2012 legislative changes mean that suitably
qualified nurses (Table 2) can now independently prescribe
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any drug, including schedule 2–5 controlled drugs, for any
medical condition within their clinical competence. As a
result of this series of legislative changes, nurses in the UK
have the most extensive prescribing rights of nurses world-
wide. Currently, there are approximately 20,000 NIPs regis-
tered with the Nursing and Midwifery Council in the UK
(Stewart et al. 2013). Many believe that nurse prescribing in
the UK improves access to medications for patients by
increasing the availability of healthcare providers who can
prescribe, and represents a more efficient use of skills through
utilising the existing expertise within the nursing workforce
(Latter et al. 2011).
In this review, we explore the impact of the extended
prescribing rights of UK NIPs on nurse-led services for
patients with attention-deficit/hyperactivity disorder
(ADHD) and examine the potential benefits of expanding
the delivery of nurse-led ADHD services in the UK. In
2005, a Cochrane review evaluated the impact of substi-
tuting nurses for doctors in primary care, concluding that
appropriately trained nurses can provide care of equally
high quality to that provided by primary care doctors and
can achieve equally good health outcomes for patients
(Laurant et al. 2005). However, the authors urged caution
in interpreting their conclusions because data from high-
quality studies were very limited. Furthermore, this earlier
review included studies published from 1966 to 2002 and
was not limited to UK studies; hence, it is unclear how
applicable these findings are to the current UK nursing
environment. Here, we examine the published literature (to
July 2013) to investigate whether the predicted benefits of
nurse independent prescribing in mental health settings can
be supported by empirical evidence, with a specific focus
on the management of patients with ADHD. Approaches to
the further development of nurse-led ADHD services in the
UK are also discussed.
Introduction to ADHD
ADHD is one of the most common neurodevelopmental
disorders in children, affecting both boys and girls, and
continuing into adulthood in many patients (Polanczyk
et al. 2007; Willcutt 2012). The disorder is characterised by
persistent symptoms of hyperactivity/impulsivity and/or
inattention and, in the long term, is associated with sig-
nificant impairments in multiple aspects of the patient’s
life, including academic performance, employment status,
interpersonal relationships, financial planning and legal
issues (Mattingly 2011; Coghill et al. 2008). Managing and
supporting patients with ADHD requires a multimodal
approach and involves interactions with multiple groups,
for example, patients’ families, educational establishments,
employers and the criminal justice system (National Insti-
tute for Health and Clinical Excellence 2009; Nutt et al.
Table 1 Changes to the misuse of drugs regulations 2001 (April
2012)
Changes relating to independent prescribing of controlled drugs in
the UK came into force on 23 April 2012 [Misuse of Drugs
(Amendment No. 2) (England, Wales and Scotland) Regulations
2012 (Statutory Instrument 2012/973)]
Previous restrictions were removed, allowing independent nurse
prescribers to:
Prescribe any controlled drug listed in schedules 2–5 for any
medical condition within their competence, with the exception
of diamorphine, cocaine and dipipanone for the treatment of
addiction
Requisition schedule 2–5 controlled drugs and to possess,
supply, offer to supply and administer them
Mix any drugs listed in schedules 2–5 before administration
These rights also apply to pharmacist independent prescribers
Persons acting in accordance with the directions of a nurse or
pharmacist independent prescriber are authorised to administer
schedule 2–5 drugs
Table 2 Nurse independent prescribing: UK training requirements
Nurses must complete a Nurse and Midwifery Council-accredited
prescribing course through an Approved Education Institution
(AEI; a UK university) that:
Includes a minimum of 26 days of teaching
For distance-learning programmes, there must be a minimum
of eight face-to-face taught days
Includes 12 days of supervised learning in practice
Is provided at a minimum of first degree level (academic level 3)
AEIs may offer the course at Masters level
Is completed within one academic year
To be eligible to undertake an accredited nurse prescribing course,
nurses must:
Be a registered first-level nurse, midwife and/or specialist
community public health nurse
Have at least 3 years’ experience as a practising nurse, midwife
or specialist community public health nurse
The year immediately preceding the programme must have
been in the clinical field in which they intend to prescribe
Be deemed competent by their employer to undertake the
programme
The employer is responsible for confirming that each nurse is
competent in history-taking, clinical assessment and
diagnosing, and possesses appropriate numeracy skills
The employer must provide written confirmation of their
support for each nurse to undertake the course
Provide evidence via the Accreditation of Prior and Experiential
Learning process of their ability to study at degree level
Obtain written confirmation from the course lead about their
acceptance on the course
Obtain written confirmation from a designated medical
practitioner who meets eligibility criteria for medical
supervision of nurse prescribers and who has agreed to provide
supervised practice
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2007). Optimal management of ADHD aims not only to
minimise the symptoms of ADHD but also to reduce the
impairments associated with the disorder. When pharma-
cological treatment for ADHD is indicated, the most
commonly used agents, both in the UK and worldwide, are
stimulant medications, which are schedule 2 controlled
drugs (Garfield et al. 2012; Knopf et al. 2012; McCarthy
et al. 2012). Therefore, UK nurses can now independently
provide a complete and holistic package of care for indi-
viduals with ADHD as a direct result of the 2012 legisla-
tive changes.
Do UK nurses have the skills required to diagnose
ADHD?
General principles of diagnosing ADHD
Like many mental health conditions, ADHD must be
diagnosed clinically; there are no definitive and objec-
tive tests (e.g. genetic or neuropsychological tests).
Diagnosis can also be complicated by the fact that
patients with ADHD often have co-existing psychiatric
disorders. However, high levels of diagnostic certainty
can be achieved through use of diagnostic rating scales
in combination with a developmental history, observa-
tion, and the assessment of family and other risk factors
(Nutt et al. 2007). According to the UK’s National
Institute for Health and Care Excellence (NICE) guide-
lines, for a diagnosis of ADHD, symptoms of hyper-
activity/impulsivity and/or inattention should meet the
diagnostic criteria in the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV)
or the International Statistical Classification of Diseases
and Related Health Problems, 10th Revision (ICD-10)
(hyperkinetic disorder), be associated with at least
moderate psychological, social and/or educational or
occupational impairment and occur in two or more
important settings including social, familial, educational
and/or occupational settings (National Institute for
Health and Clinical Excellence 2009). NICE guidelines
have yet to be updated to reflect the recently published
Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-5), but it is noteworthy that DSM-5
differs from its predecessor in requiring several inat-
tentive or hyperactive symptoms to be present before
12 years of age, compared with the presence of symp-
toms that cause impairment prior to the age of 7 years in
DSM-IV (American Psychiatric Association 2013).
Based on the high degree of clinical judgement required
to make a diagnosis, expertise in the field of ADHD is
needed in order for both doctors and nurses to make
accurate diagnoses of the condition.
Independent diagnosis by UK nurses: lessons
from other therapy areas
Nurses diagnose various medical conditions in clinical
practice. In a UK study, 73.8 % of NIPs surveyed
(n = 862), working across a range of therapy areas,
reported that they made the diagnosis on most occasions in
their prescribing practice (Latter et al. 2011). Despite this,
the number of studies assessing the accuracy of diagnosing
by UK nurses in any disease area is currently limited. The
ability of nurses to diagnose headache disorder to the same
standard as doctors was established in a small UK study
involving one neurology ward sister, trained in the differ-
ential diagnosis of headache disorder, and three consultant
neurologists (Clarke et al. 2005). Following examination of
239 patients and 13 role-players, the doctor’s primary
diagnosis was reached by the nurse in 90 % of cases of
headache and migraine, and 61 % of other diagnoses
(Clarke et al. 2005). Of the 30 cases in which the nurse did
not reach the same diagnosis as the doctor, 22 were
referred for further evaluation. Examination of patients’
records at least 6 months after participation indicated that
no sinister headache pathologies were missed, suggestive
of high quality diagnosing by the nurse and the consultants
(Clarke et al. 2005).
The quality of nurse diagnosing was also examined in a
retrospective case note study, which examined the records
of 404 UK patients diagnosed with dementia (Page et al.
2008). The study compared the initial diagnoses of two
nurses with subsequent formal diagnoses at a multidisci-
plinary memory clinic, revealing that the nurses accurately
detected dementia in 94 % of cases (Page et al. 2008).
However, interpretation of both of these studies is limited
owing to the very small numbers of nurses involved.
The ability of nurses to diagnose medical conditions
accurately is further supported by two larger studies (Latter
et al. 2011, 2012; Naughton et al. 2012). The first reviewed
100 audio-recordings of consultations by NIPs (n = 52)
and pharmacist independent prescribers (PIPs; n = 48)
using the Medication Appropriateness Index (MAI; Latter
et al. 2011, 2012). In 87.5 % of cases reviewed, an
‘appropriate’ rating was awarded for the MAI item ‘Is there
an indication for the medication?’ suggestive of appropri-
ate diagnosing practice (Latter et al. 2011, 2012). The
largest number of comments provided by the MAI raters
was in praise of the prescribing episode (88/272 comments;
Latter et al. 2011, 2012). However, the second most fre-
quent group of comments related to the potential for
improvements in independent prescribers’ history-taking,
assessment and diagnosis skills (52 comments; Latter et al.
2011, 2012). In agreement with this study, an MAI study of
nurse prescribers in Ireland (including 142 patient records)
found that the prescribed medication was appropriately
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indicated in 95 % of cases (Naughton et al. 2012). There-
fore, evidence is available to support the idea that UK
nurses can diagnose medical conditions accurately, but
further research is required to endorse this claim.
Independent diagnosing of ADHD by nurses
There are currently no studies that have examined the
ability of UK nurses to diagnose ADHD accurately; how-
ever, two studies were identified that examined the ability
of non-UK-based nurses to diagnose ADHD. First, a US-
based study concluded that advanced practice registered
nurses followed American Academy of Pediatrics diag-
nostic guidelines for ADHD in children more closely than
did other healthcare providers (paediatricians and family
physicians; Vlam 2006). Of the nurses surveyed, 52 %
were confident in making an ADHD diagnosis (Vlam
2006); however, interpretation is limited as the study did
not report the proportion of clinicians who were confident
in diagnosing ADHD. Low levels of confidence in diag-
nosing ADHD in children and adults were found in a
second study of US nurse practitioners (Knutson and
O’Malley 2010). However, conclusions from this study are
also severely limited because 74.3 % of nurses included in
the study indicated that they had never diagnosed ADHD in
children, and 66.5 % had never diagnosed the disorder in
adults. Clearly, empirical evidence to establish the accu-
racy of ADHD diagnosing by UK nurses is lacking, and if
the provision of nurse-led ADHD services were to be
expanded, this is an area in which further research is
needed.
Is independent prescribing by UK nurses safe
and appropriate?
Safe and clinically appropriate prescribing
Several studies in the UK and Ireland have found that
non-medical prescribing (which includes prescribing by
nurses and pharmacists) is safe and clinically appropriate
(Black 2013; Latter et al. 2011, 2012; Naughton et al.
2012). Latter et al. (2012) reviewed 100 audio-recordings
of consultations using the MAI, concluding that NIPs
(n = 52) and PIPs (n = 48) were making clinically
appropriate prescribing decisions (Latter et al. 2011,
2012). High levels of ‘appropriate’ rating were awarded
for most MAI items (range 79–93.5 % for 9/10 items),
with the lowest score recorded for the item ‘Is this drug
the least expensive alternative to others of equal utility?’
(69.5 %) (Latter et al. 2011, 2012). This study states that
their findings are broadly consistent with those from
MAI studies investigating doctors’ prescribing decisions,
but urges caution owing to the lack of directly compa-
rable studies (Latter et al. 2012). The MAI was also used
to evaluate clinical appropriateness and safety of nurse
and midwife prescribing in Ireland, concluding that
69–80 % of prescribing episodes were deemed appro-
priate across all eight MAI items assessed (Naughton
et al. 2012).
A retrospective review of 764 NIPs’ case notes in
accident and emergency and sexual health concluded that
prescribing practice was safe in 99.4 % of cases (n = 566)
(Black 2013). However, improved documentation was
required in eight cases, and in two of these, the prescribing
episode was deemed unsafe owing to the lack of docu-
mented past medical history (Black 2013). As with the
other studies described here, comparisons with medical
colleagues were not included in this study, making the
findings difficult to interpret. No studies were identified
that specifically examined the safety or clinical appropri-
ateness of independent nurse prescribing for ADHD, in the
UK or elsewhere. This is not surprising as UK nurses have
been able to prescribe stimulants independently, without
the need for a clinical management plan, only since April
2012. Therefore, data regarding the safety or clinical
appropriateness of independent nurse prescribing for
ADHD in the UK have yet to become available. The
generation of these data will be highly valuable in guiding
the future expansion of nurse-led ADHD services.
Prescriber confidence
Studies indicate that NIPs have high levels of confidence in
their prescribing abilities (Gumber et al. 2012; Latter et al.
2011). Only 6 % of 862 UK NIPs surveyed (working
across a range of therapy areas including mental health)
had concerns that they were prescribing outside their
competency, compared with 9.8 % of 143 UK PIPs (Latter
et al. 2011). In addition, only 4.0 % of NIPs, compared
with 10.5 % of PIPs, agreed with the statement ‘I do not
have the pharmacological knowledge to be a safe inde-
pendent prescriber’ (Latter et al. 2011). It is notable,
however, that 58 % of NIPs surveyed, compared with
28.2 % of PIPs, expressed concerns about prescribing for
patients with comorbidities (Latter et al. 2011). This point
is particularly pertinent to ADHD treatment as the disorder
is frequently associated with psychiatric comorbidities.
In a second UK study, all 20 mental health non-medical
prescribers surveyed (which included 18 nurses) believed
that they worked within their competency, and most agreed
that they had adequate knowledge of side effects, dosage,
drug interactions, withdrawal effects and physical health
monitoring (Gumber et al. 2012).
The NIP qualification requires a minimum of 12 days of
supervised learning in practice by a designated medical
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practitioner. In a survey of 840 NIPs, this supervised
practice was considered a highly positive experience and
55.0 % of NIPs reported receiving more than the 12 days
required of supervised practice (Latter et al. 2011). The use
of clinical supervision is likely to enhance the confidence
of NIPs and also provides quality assurance.
Attitudes among medical colleagues
Studies investigating the opinions of UK doctors towards
independent nurse prescribing in mental health settings
have yielded mixed results. In semi-structured interviews,
two psychiatrists with experience of working with NIPs
expressed positive views on the competency of NIPs and
the benefits they can bring to patient care (Earle et al.
2011b). Both psychiatrists, however, stressed the impor-
tance of adequate supervision (Earle et al. 2011b). In a
larger study involving 147 psychiatrists, just over half of
consultants felt that mental health nurses should be able to
prescribe independently, whereas 80 % of junior doctors
felt that they should not (Rana et al. 2009). In contrast,
significantly more junior doctors than consultants felt that
nurses should be able to prescribe out of hours and at
weekends (Rana et al. 2009). Only 20 % of consultants and
none of the junior doctors surveyed felt that nurses should
be able to prescribe controlled drugs (Rana et al. 2009).
Notably, across the entire survey, senior psychiatrists had
fewer concerns about the creation of new nursing roles than
their junior colleagues, possibly reflecting higher levels of
anxiety among junior doctors (Rana et al. 2009).
In apparent contrast to these findings, 87 % of NIPs
believed that the doctors they worked with were supportive
of nurse independent prescribing in a more recent UK
study that was not restricted to mental health settings, and
54 % agreed that independent prescribing had increased
the respect they received from doctors (Latter et al. 2011).
It is possible that these discrepancies reflect rapidly
changing viewpoints as the role of non-medical prescribers
expands and doctors gain greater experience of working
with NIPs, or they may reflect a particular reluctance
towards non-medical prescribing in mental health settings.
Treating and managing patients with ADHD in the UK
ADHD treatments
In the UK, psychoeducational and behavioural interventions
are recommended as first-line treatments for children and
adolescents with mild or moderate impairment resulting
from ADHD (National Institute for Health and Clinical
Excellence 2009). These include parent-training/education
programmes and group treatment programmes for the
patient (cognitive behavioural therapy and/or social skills
training). Pharmacological treatment is generally reserved
for children and adolescents with more severe symptoms.
Stimulants (methylphenidate- and amphetamine-based for-
mulations) and the non-stimulant atomoxetine are approved
medications for the treatment of ADHD in children and
adolescents in the UK, with methylphenidate the most
commonly prescribed medication (National Institute for
Health and Clinical Excellence 2009). For adults in the UK,
pharmacological treatment, and specifically methylpheni-
date, is recommended as first-line therapy (National Institute
for Health and Clinical Excellence 2009). Stimulants are
schedule 2 controlled drugs; hence, the recent legislative
changes allow UK NIPs to prescribe any of the licensed
ADHD medications independently. The evidence presented
in the previous section suggests that nurses are equipped to
expand their role to include independent prescribing of
stimulants. As mentioned earlier, powers to prescribe stim-
ulants were only recently granted to NIPs, and as such, there
is as yet no empirical evidence available to either support or
refute this suggestion. Establishing the safety and clinical
appropriateness of NIP-controlled drug prescribing, includ-
ing ADHD medications, is highly desirable.
Managing patients with ADHD
Managing and supporting patients with ADHD involves
interactions with multiple groups, including parents and
other carers, teachers/lecturers and the criminal justice
system. These interactions are time-consuming and require
flexibility. For those patients receiving ADHD medication
additional, regular monitoring is required, for example,
measuring height, weight, blood pressure and pulse,
assessing side effects, determining the efficacy of treat-
ment, deciding whether dose adjustments or treatment
switches would be beneficial, and establishing the need for
continued treatment (National Institute for Health and
Clinical Excellence 2009).
Support is also needed to enhance adherence to treat-
ment regimens because, like other chronic health condi-
tions, adherence to ADHD medication is low; a review of
11 studies in children and adults with ADHD reported
mean rates of non-adherence to medication of 13–64 %
(Adler and Nierenberg 2010). Adherence can be particu-
larly problematic in adolescents and adults as parental
supervision is reduced, with these individuals particularly
vulnerable to dropping out of ADHD services during
transitions from paediatric to adult care (Taylor et al.
2010). As a result, these patients require even greater levels
of support from healthcare providers. Given the chronic
nature of ADHD, non-adherence to treatment can be a
major determinant of treatment outcome and can have huge
health, social and economic implications.
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The role of nurse-led services in managing patients
with ADHD in the UK
The available data, discussed below, indicate that nurses
can deliver high-quality care for patients with ADHD and
can enhance the experience of service users owing to the
unique nurse–patient relationship. The particular aspects of
nurse-led care that we predict are most likely to lead to
improved patient satisfaction and outcomes are outlined in
Table 3.
Increasing client satisfaction
Several studies indicate that there are high levels of satis-
faction with nurse prescribing in UK mental health settings
among clients (which include patients and carers; Earle
et al. 2011a; Laver-Bradbury and Harris 2009; Ross et al.
2013). Five out of six patients interviewed did not feel that
there were any disadvantages or concerns regarding nurse
prescribing in a survey of patients from one UK mental
health National Health Service (NHS) trust (Earle et al.
2011a). Patients particularly valued the convenience of
home visits and believed that nurses provided longer and
more frequent appointments than doctors. Patients also
reported feeling less intimidated speaking to a nurse than a
doctor, highlighting the importance of the unique nature of
the nurse–patient relationship. Two patients recognised,
however, that some individuals may prefer to see a doctor
and believed that doctors had greater knowledge than
nurses (Earle et al. 2011a). Similarly, high levels of satis-
faction with nurse prescribing were found among nine
clients from another UK mental health NHS trust, with
many clients believing that nurse prescribing had
strengthened the nurse–patient relationship and had
improved access to care (Ross et al. 2013).
Parents (n = 12) of UK-based patients with ADHD
were found to be at least as satisfied with the care received
from ADHD advanced nurse practitioners as with that
previously provided by medical staff (Laver-Bradbury and
Harris 2009). This study also found that parental views on
support groups (n = 28) were almost entirely positive.
Some of the parents completed the General Health Ques-
tionnaire (GHQ; n = 15) and the Parenting Sense of
Competency Questionnaire (PSOC; n = 13) before and
after attending support groups. Using the GHQ, 12 parents
had an initial score greater than 12 (indicating health
problems), whereas, 4 weeks after starting to attend the
support group, only six parents had a score greater than 12
(Laver-Bradbury and Harris 2009). In addition, there were
statistically significant improvements in mean PSOC ‘total’
and ‘satisfaction’ scores 4 weeks after starting to attend the
support group, indicating improved levels of parenting
competency and satisfaction (Laver-Bradbury and Harris
2009). The same study collected parental feedback on
nurse-led drop-in clinics, revealing that this service was
highly valued by parents who particularly appreciated the
access to professional advice and support between clinical
appointments, and the flexibility to attend at a time that was
convenient for them (Laver-Bradbury and Harris 2009).
Parental views were also investigated in a Canadian
continuity of care study that sought opinions of parents of
children with complex chronic health conditions, including
children with ADHD (Miller et al. 2009). This study
indicated that parents highly valued care in which knowl-
edge of the child was developed through relationships with
a consistent set of service providers, both inside and out-
side medical settings (Miller et al. 2009).
Nurses are in a position to offer flexible services to
patients with ADHD and their parents, and can also interact
with non-medical service providers involved in provision of
patient care (e.g. teachers). The legislative changes permit-
ting the prescribing of controlled drugs by NIPs provide the
opportunity for nurse-led ADHD services to offer a com-
plete package of care to individuals with ADHD, facilitating
enhanced engagement with patients and carers and improved
continuity of care, which would be expected to lead to
increased levels of client satisfaction.
Table 3 Opportunities for nurse-led services to enhance ADHD care
Independent prescribing: timely access to treatment
Nurses can initiate new treatment or modify the dose/formulation
of medication instantly without the need to refer to a clinician
Patient care can be improved by allowing rapid balancing of
symptom control and side effects
Continuity of care
Nurses can deliver a complete, multimodal care package
Nurses can regularly interact with individuals involved in patient
care (e.g. parents, schools and the criminal justice system) in
clinical and non-clinical settings
Nurses can get to know patients and their families over an
extended period of time, facilitating individualised treatment
strategies
Longer and more frequent appointments
Nurses can provide increased consultation time, facilitating
greater patient understanding of treatment regimens; this is
linked to improved adherence to treatment
Named nurse contact details
Patients, parents, schools and other relevant parties can obtain
rapid guidance on the treatment of individual patients
Patient and parent support
Nurses can run support groups and drop-in clinics for patients
and/or parents
Nurse–patient relationship
Patients and parents may feel less intimidated by nurses than by
clinicians, thus facilitating open and honest discussion of their
symptoms/behaviours and treatment adherence
274 L. Mangle et al.
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Promoting adherence to treatment
As with other chronic health conditions, improving
adherence to treatment is key to maintaining effective
control of symptoms and problem behaviours associated
with ADHD. Adherence to ADHD medications is consis-
tently higher among patients involved in clinical trials than
among those receiving treatment in the community
(Chacko et al. 2010). These observations provide indirect
evidence that longer and more frequent follow-up
appointments may lead to increased adherence among
patients with ADHD. Interventions that have been identi-
fied to enhance adherence to long-term treatment in general
include combinations of the following: more convenient
care; information; counselling; reminders; self-monitoring;
reinforcement; family therapy; psychological therapy;
mailed communications; crisis intervention; manual tele-
phone follow-up; and other forms of extra supervision or
attention (Haynes et al. 2008).
No studies were identified that assessed the impact of
nurse-led care on adherence specifically to ADHD medi-
cation. However, several studies have demonstrated that
nurse-led interventions can improve adherence in other
therapy areas. A systematic review of articles published
from 2006 to 2011 identified 10 randomised controlled
trials on nurse-led interventions aimed at improving
chronic medication adherence in adults (Van Camp et al.
2013). Included studies were conducted in the USA
(n = 5), Europe (n = 3), Asia (n = 1) and Africa (n = 1),
with seven studies focused on patients who were HIV-
positive and the remaining three assessing patients with
depression, arthritis and hypertension (Van Camp et al.
2013). Most interventions were multifactorial, combining
counselling with education, social support and practical
help (e.g. text message reminders). Nurse-led interventions
enhanced short-term adherence in nine studies (results
were statistically significant in four studies), and the
intervention effect was sustained in the long term
(3–12 months post-intervention) in eight studies (results
were statistically significant in four studies; Van Camp
et al. 2013).
In a randomised UK-based study assessing adherence
to inhaled combination therapy in adult patients referred
to a Regional Difficult Asthma Service, a nurse-delivered
intervention strategy led to significantly increased adher-
ence at 12 months relative to the control group (Gamble
et al. 2011). There was also a non-significant trend
towards fewer hospital admissions in the intervention
group at 12 months. In addition, a randomised UK-based
trial in adult patients with type 2 diabetes found that a
nurse-delivered consultation-based intervention increased
objectively measured medication adherence (Farmer et al.
2012).
How effective are UK-based nurse-led care models
for ADHD?
In the UK, nurse-led services are being used effectively to
manage a variety of health conditions (e.g. diabetes, pain
management and smoking cessation). However, the data
available to assess the quality of nurse-delivered manage-
ment of patients with ADHD are, so far, limited. The
quality of nurse-led and doctor-led management was
compared in patients with ADHD who had been previously
diagnosed and titrated to a stable medication dose by a
doctor (Foreman and Morton 2011). The study, which
included two doctors and one ADHD nurse, indicated that
all three individuals provided very similar standards of care
when assessing symptomatic change, side-effect burden
and service user satisfaction (Foreman and Morton 2011).
Care delivered by nurses was found to be as good as that
delivered by doctors even in more complex cases of ADHD
(Foreman and Morton 2011). However, interpretation of
these data is limited owing to the low numbers of health-
care providers included in the study.
Contact with UK schools was enhanced when they were
provided with a specific named nurse to contact regarding
the management of a child with ADHD, and schools
reported that the provision of nurse-based intervention had
been beneficial to the children (Laver-Bradbury and Harris
2009). The same study also indicated that nurse-led inter-
ventions led to improvements in patient outcomes (Laver-
Bradbury and Harris 2009). Parents completed the
Strengths and Difficulties Questionnaire (SDQ; n = 13)
before and after attending nurse-led support groups (over a
4-week period; Laver-Bradbury and Harris 2009). The
results of the SDQ, which assesses changes in parents’
reports on their child’s strengths and difficulties, revealed
statistically significant improvements after attending the
support groups in the ‘hyperactivity’ and ‘peer problems’
domains (though not in ‘emotional symptoms’, ‘conduct’
or ‘prosocial behaviour’ domains), indicating that the
flexible working practices that can be employed by nurses
not only may enhance parent satisfaction (described pre-
viously), but also may lead to some improvements in
patient outcomes (Laver-Bradbury and Harris 2009).
Therefore, initial evidence obtained in ADHD and other
therapy areas indicates that nurse-led services are very well
placed to provide high-quality, complete care packages for
patients with ADHD, and it is hoped that further empirical
evidence will be generated to confirm this prediction.
Relevance of findings to non-UK healthcare settings
This review specifically focuses on the empirical evidence
available to support the potential benefits of nurse-led
ADHD services in the UK healthcare setting, where nurses
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currently have the most extensive prescribing rights of
nurses worldwide. Outside of the UK, the ability of nurses
to prescribe controlled ADHD medications varies. For
example, it is not permitted at all in Germany, whereas in
Australia controlled drug prescribing is permitted by a
subset of nurses working in rural and isolated practice.
Given the fact that widespread controlled drug prescribing
by nurses is not generally permitted in countries other than
the UK, nurse-led ADHD services outside of the UK would
not currently be able to offer the holistic care packages
possible for UK services. However, many aspects of these
findings are likely to be relevant to nurses in other coun-
tries, and as nurse-led prescribing becomes increasingly
embedded in the UK health system, healthcare providers
elsewhere are likely to draw on the UK’s experiences in
expanding the nursing role to better utilise the existing
skills within their own nursing workforces.
Cost-effectiveness of independent nurse prescribing
It has been suggested that independent prescribing by
nurses allows existing skills within the nursing sector to be
implemented and utilised more efficiently; this allows
doctors’ time to be spent on more complex cases, thus
providing economic benefits (Latter et al. 2011). However,
the evidence to support these claims remains limited. In the
2005 Cochrane review, the authors agreed that doctor–
nurse substitution had the potential to reduce healthcare
costs (Laurant et al. 2005). However, they suggested that
savings were likely to be highly dependent on the salary
differential between doctors and nurses, and may be offset
by lower productivity of nurses compared with doctors
(Laurant et al. 2005).
More recently, a UK study performed a cost-minimisa-
tion analysis using an infection vignette (Latter et al. 2011).
This study concluded that a combined general practitioner
(GP) and NIP service for infection was less expensive than
a traditional GP-only service at practice and primary care
trust levels (training costs not considered; Latter et al.
2011). Cost benefits were also reported when nurse pre-
scribers, rather than doctors, reviewed and monitored
medication for patients with ADHD in the UK, even
though patients were seen more often after they were
transferred to nurse care (Laver-Bradbury and Harris
2009). Although cost-effectiveness was not assessed
directly, another UK study concluded that the management
of patients with ADHD by nurses was of a similar standard
to that provided by doctors and suggests that nurse-led care
would substantially reduce costs with no loss of quality
(Foreman and Morton 2011). Therefore, based on available
data, it appears likely that nurse-led ADHD services could
provide cost benefits compared with clinician-delivered
care, but this prediction has yet to be fully supported by
empirical evidence. If nurse-led services resulted in
improved outcomes for patients with ADHD (in terms of
impairments across their lifespan), there would be far-
reaching cost benefits to society as well as reduced
symptoms and improved quality of life for the individual.
Care must be taken, however, that a desire for cost-
effectiveness does not overshadow the requirement for a
safe and effective ADHD service. It must be ensured that
all staff, whether working in a nurse-led service or not,
have adequate training in the multifaceted process of
diagnosing and treating ADHD. In addition, it would seem
wise that nurse-led ADHD services should remain affiliated
with medical colleagues to aid in the care of patients with
complex needs and to assist in the management of adverse
events that may occur as a result of pharmacological
treatment for ADHD.
Barriers to implementation of independent nurse
prescribing in mental health settings
In the UK, barriers to implementation of nurse prescribing
in mental health settings include lack of support, role
conflict with other healthcare professionals, concerns about
the effect on the relationship with patients, concerns about
the level of training and lack of recognition for additional
responsibilities (via job status and remuneration; Earle
et al. 2011a; Gumber et al. 2012; Jones et al. 2010; Ross
and Kettles 2012).
Lack of support
Despite legislative changes permitting independent pre-
scribing by nurses, some NHS Trusts have not imple-
mented this widely. A survey investigating barriers to
prescribing by UK mental health NIPs (n = 33) found that
only half of respondents felt supported in their role (Ross
and Kettles 2012). Lack of medical supervision, clear
prescribing policy and clinical governance were identified
as further barriers (Ross and Kettles 2012). NIPs were also
frustrated by the influence of nurse management on their
prescribing role and suggested that nurse managers did not
have sufficient knowledge of prescribing to warrant such
influence (Ross and Kettles 2012). It should be noted that,
despite being appropriately trained, 58 % of NIPs included
in this study had never prescribed independently, perhaps
resulting in particularly negative viewpoints.
Insufficient training
Some studies have raised concerns about whether UK
nurses are equipped with the required knowledge of
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pharmacology (Jones et al. 2010), numerical skills, drug
calculation abilities (McMullan 2010) and competence in
pharmacovigilance (Stewart et al. 2013) to fulfil the addi-
tional responsibilities associated with independent pre-
scribing. Despite the fact that 76 % of mental health NIPs
surveyed in the study by Ross and Kettles (2012) felt
confident to prescribe, 55 % did not feel that the pre-
scribing course had prepared them to do so (Ross and
Kettles 2012). This view was shared in another survey of
non-medical prescribers (n = 20) working in UK mental
health settings, which found that 60 % agreed that there
were shortfalls in training and supervision (Gumber et al.
2012). However, this finding is difficult to interpret owing
to the fact that 70 % of responders agreed that they per-
sonally had received adequate supervision, with 80 %
agreeing that they themselves had received adequate
training in prescribing (Gumber et al. 2012).
As a possible solution to the potential training shortfall,
one study of UK mental health NIPs (n = 13) demon-
strated that a 10-day psychopharmacology course, costing
£300 per participant, led to statistically and clinically sig-
nificant gains in knowledge (Jones et al. 2010). The authors
proposed that a portion of the prescribing course should be
dedicated to specific training according to the disease area
in which the trainee NIPs intend to practise (Jones et al.
2010). A study of ADHD nursing in the UK also identified
a need for expansion of the nurse prescribing course to
include children and young people’s mental health (Laver-
Bradbury and Harris 2009). Jones et al. (2010) suggest that
a greater understanding of psychopharmacology may
increase the confidence of mental health nurses who hold
the prescribing qualification, thus increasing the numbers
who choose to use their prescribing qualification in practice
(Jones et al. 2010). This opinion would appear to be sup-
ported by Ross and Kettles (2012), who found that nurses
with higher qualifications were more confident to prescribe
independently (Ross and Kettles 2012).
Lack of recognition
Many NIPs believe that the additional levels of expertise
and responsibilities associated with their prescribing role
should be recognised in their job description and finan-
cially rewarded (Earle et al. 2011a; Jones et al. 2010; Ross
and Kettles 2012). NIPs have also expressed the concern
that the expansion of non-medical prescribing is politically
motivated, suggesting that they were being paid cheaply to
do the same job as doctors (Ross and Kettles 2012).
Overcoming barriers to prescribing
Despite these identified barriers and reservations, there is
evidence to indicate that NIPs who are actively prescribing
have higher levels of job satisfaction than those who are not
(Cousins and Donnell 2012; Ross and Kettles 2012). In a
Department of Health evaluation, 54.2 % of NIPs indicated
that the decision to become a prescriber had been driven by
their own personal choice, with 38.5 % reporting that it was a
joint decision with their employer (Latter et al. 2011). This
may suggest that self-motivated individuals and those who
are supported by appropriate management and service
structures are able to overcome the perceived barriers to
independent prescribing. Improving the professional support
for newly qualified NIPs may allow greater numbers of
trained NIPs to overcome these barriers to prescribing,
reducing the waste of NHS resources associated with training
nurses to prescribe who do not then feel able to do so.
Conclusions
The symptoms and functional impairments associated with
ADHD can negatively impact many aspects of patients’
lives and also present challenges for their parents, carers,
teachers and employers. ADHD can be effectively man-
aged, but this requires a multimodal treatment approach
which can be time-consuming and labour intensive for
healthcare providers. Legislative changes that came into
effect in April 2012 permit UK nurses to prescribe sche-
dule 2–5 controlled drugs, including stimulant medications
for the treatment of ADHD, independently. This means that
nurse-led services in the UK can now provide a full
package of care for patients with ADHD.
We believe that UK ADHD nurses possess the required
specialist skills and experience to deliver high-quality,
holistic care for patients with ADHD. We also believe that
nurse-led services have the potential to enhance the expe-
rience of patients with ADHD and their carers, and to
deliver improved patient outcomes compared with standard
care models. While multiple small-scale studies support the
potential benefits of nurse independent prescribing, there
are few large-scale studies and even fewer studies that
directly compare nurse-delivered care with that of medical
colleagues. Importantly for this review, none of the iden-
tified large-scale studies have specifically assessed nurse-
delivered care for patients with ADHD, with evidence
limited to a few small-scale studies. Latter et al. (2011)
indicated that the expansion of nurse-led services to date
has been largely driven by individual practitioners (Latter
et al. 2011); we urge ADHD nurses in the UK also to drive
the collection of high-quality study data, and the publica-
tion of peer-reviewed reports, to allow the value of nurse-
delivered ADHD care to be scientifically verified. This
evidence will be invaluable in supporting the growth of
nurse-led ADHD services and for those who support
greater remuneration for the expanded role of NIPs.
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